APC
LLY icon

Aspire Private Capital’s Eli Lilly LLY Stock Holding History

Aspire Private Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.58M Sell
2,150
-396
-16% -$405K 0.53% 45
2026
Q1 		$2.34M Buy
2,546
+43
+2% +$43.6K 0.53% 44
2025
Q4 		$2.69M Sell
2,503
-212
-8% -$203K 0.6% 42
2025
Q3 		$2.07M Buy
2,715
+348
+15% +$259K 0.46% 51
2025
Q2 		$1.85M Buy
2,367
+71
+3% +$55.2K 0.43% 52
2025
Q1 		$1.9M Buy
2,296
+156
+7% +$130K 0.47% 47
2024
Q4 		$1.65M Buy
2,140
+392
+22% +$325K 0.41% 51
2024
Q3 		$1.55M Buy
1,748
+16
+0.9% +$14.4K 0.37% 52
2024
Q2 		$1.57M Sell
1,732
-18
-1% -$14.4K 0.4% 46
2024
Q1 		$1.36M Buy
1,750
+490
+39% +$349K 0.36% 45
2023
Q4 		$735K Buy
1,260
+661
+110% +$386K 0.22% 72
2023
Q3 		$322K Hold
599
– – 0.1% 108
2023
Q2 		$281K Hold
599
– – 0.09% 114
2023
Q1 		$206K Hold
599
– – 0.07% 126
2022
Q4 		$219K Hold
599
– – 0.08% 118
2022
Q3 		$194K Hold
599
– – 0.07% 123
2022
Q2 		$194K Sell
599
-3
-0.5% -$901 0.07% 125
2022
Q1 		$172K Sell
602
-13
-2% -$3.35K 0.05% 139
2021
Q4 		$170K Buy
615
+13
+2% +$3.3K 0.05% 146
2021
Q3 		$139K Hold
602
– – 0.05% 148
2021
Q2 		$138K Sell
602
-131
-18% -$26.3K 0.04% 159
2021
Q1 		$137K Buy
733
+123
+20% +$24.1K 0.05% 169
2020
Q4 		$103K Buy
610
+1
+0.2% +$149 0.04% 182
2020
Q3 		$90K Buy
609
+341
+127% +$52.8K 0.04% 177
2020
Q2 		$44K Buy
268
+258
+2,580% +$39.6K 0.02% 167
2020
Q1 		$1K Sell
10
-458
-98% -$62.9K ﹤0.01% 211
2019
Q4 		$62K Hold
468
– – 0.03% 189
2019
Q3 		$52K Sell
468
-28
-6% -$3.12K 0.02% 185
2019
Q2 		$55K Buy
496
+50
+11% +$5.89K 0.03% 194
2019
Q1 		$58K Sell
446
-300
-40% -$36.5K 0.03% 221
2018
Q4 		$86K Buy
+746
New +$83.3K 0.05% 162

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aspire Private Capital's LLY Position: Q2 2026 in Review

Aspire Private Capital reduced its Eli Lilly (LLY) stake by 16% in Q2 2026, selling an estimated $405K and leaving 2,150 shares worth $2.58M. The position accounts for 0.53% of the portfolio, ranked #45.

Aspire Private Capital first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.69M in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aspire Private Capital held 2,150 shares of Eli Lilly worth $2.58M as of Q2 2026.
  • Aspire Private Capital sold 396 Eli Lilly shares in Q2 2026, an estimated $405K.
  • Eli Lilly made up 0.53% of Aspire Private Capital's portfolio in Q2 2026, its #45 holding.
  • Aspire Private Capital first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
  • Aspire Private Capital's Eli Lilly position peaked at $2.69M in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aspire Private Capital's 13F filing for Q2 2026, filed 15 Jul 2026.